DANE.TADANE.TATLV
Loading
Danel (Adir Yeoshua) Ltd operates nursing homes and assisted living facilities across Israel, providing long-term care services for elderly and chronically ill patients. The company generates revenue primarily through government-reimbursed care services and private-pay residents, with profitability driven by occupancy rates, reimbursement rate negotiations with Israel's National Insurance Institute, and labor cost management in a healthcare labor-constrained environment.
Danel operates a portfolio of licensed nursing beds across Israel, earning per-diem rates from government payers and private residents. Profitability depends on maintaining high occupancy (typically 95%+ in mature facilities), negotiating favorable reimbursement rates with the National Insurance Institute during periodic rate reviews, and controlling labor costs which represent 60-70% of operating expenses. The company's competitive advantage lies in its scale as one of Israel's largest operators, enabling better procurement terms, shared administrative infrastructure, and stronger negotiating position with government payers. The 18.4% gross margin reflects the labor-intensive nature and regulated pricing environment, while the low 0.7% net margin indicates thin profitability typical of government-reimbursed healthcare facilities.
Government reimbursement rate changes - annual or multi-year rate negotiations with Israel's National Insurance Institute directly impact per-bed revenue
Labor cost inflation - nursing and caregiver wage pressures in Israel's tight healthcare labor market compress margins
Occupancy trends across facility portfolio - census levels above 90% drive profitability given high fixed costs
Facility expansion announcements - new bed licenses or acquisitions signal growth capacity in supply-constrained market
Regulatory changes to long-term care standards - staffing ratios, quality requirements affect operating costs
Government reimbursement pressure - Israel's fiscal constraints may limit rate increases below cost inflation, compressing margins structurally as seen in other developed markets with aging populations
Chronic healthcare labor shortages - Israel faces persistent nursing and caregiver shortages, driving wage inflation and potentially limiting expansion capacity regardless of bed licenses
Regulatory intensity increasing - quality standards, staffing ratios, and compliance costs rising across developed long-term care markets, requiring ongoing capital investment
Fragmented market consolidation - larger competitors or private equity entrants could bid up acquisition prices and compete for scarce labor, pressuring margins
Home-based care alternatives - government and private insurers increasingly favor aging-in-place models and home health services, potentially reducing nursing home demand for less acute patients
Moderate leverage at 0.66 D/E with thin 0.7% net margins creates limited buffer for operational stress or reimbursement cuts
Working capital pressure - 1.30 current ratio is adequate but not robust; any payment delays from government or increased working capital needs could strain liquidity
Capital intensity of growth - expanding bed capacity requires significant upfront investment with 2-3 year payback periods, creating execution risk
low - Long-term care demand is demographically driven by aging population rather than economic cycles. Israel's elderly population (65+) continues growing regardless of GDP fluctuations. Government reimbursement provides revenue stability, though fiscal pressures during recessions may constrain rate increases. Private-pay segment (15-25% of revenue) shows modest sensitivity to household wealth and employment, but overall business is defensive.
Rising interest rates increase financing costs for facility acquisitions and expansions, given the capital-intensive nature of real estate and equipment. The 0.66 debt/equity ratio indicates moderate leverage. Higher rates also pressure valuation multiples for healthcare REITs and facility operators, as investors compare yields to fixed income alternatives. However, operational cash flows are relatively insulated since reimbursement rates and demand are not rate-sensitive. The company's ability to pass through costs depends on government rate negotiations rather than market pricing power.
Minimal direct credit exposure - government reimbursement from National Insurance Institute represents low default risk. Private-pay receivables carry modest collection risk but are small portion of revenue. The company's own credit access matters for growth capital, and tighter credit conditions could constrain expansion plans or increase refinancing costs on the existing debt load.
value - The 1.0x P/S and 6.9% FCF yield suggest value orientation, with investors attracted to defensive healthcare exposure and demographic tailwinds despite thin margins. The 282% net income growth (off low base) and improving profitability may attract turnaround investors. Dividend potential from the positive free cash flow appeals to income-focused investors seeking defensive yield in Israeli equities.
moderate - Healthcare facility operators typically exhibit lower volatility than broader market given stable, government-backed revenue streams. However, the thin 0.7% net margin means small operational changes or reimbursement adjustments create outsized earnings volatility. The -1.8% six-month return vs +6.2% one-year return suggests recent consolidation after a stronger run. Israeli market concentration and lower liquidity may amplify volatility vs comparable US or European peers.